acetogenins - CISMeF

Preferred Label : acetogenins;

MeSH definition : Polyketides of up to a few dozen carbons in length, formed by chain extension of multiple PROPIONATES and oxygenated to form tetrahydrofuran and lactone rings along the length of the chain. They are found in ANNONACEAE and other PLANTS. Related compounds cyclize to MACROLIDES.;

MeSH synonym : acetogenin compounds;

MeSH hyponym : annonaceous acetogenins; Acetogenins, Annonaceous;

Wikipedia link : https://en.wikipedia.org/wiki/Acetogenins;

Is substance : O;

Details

Origin ID

D054378;

UMLS CUI

C1435950;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- acetogenins [IUPAC Term]
Record concept(s)
- acetogenins [MeSH concept]
- annonaceous acetogenins [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2E,6Z)-8,9,10-trihydroxy-4-hydroxymethyl-2,6-decadiene [MeSH Supplementary Concept]
- (2E,6Z)-9,10-dihydroxy-4-hydroxymethyl-2,6-decadiene [MeSH Supplementary Concept]
- (2E,6Z)-9-hydroxy-4-hydroxymethyl-2,6-nonadiene [MeSH Supplementary Concept]
- 12,15-cis-squamostatin-A [MeSH Supplementary Concept]
- 2,3,7,7a-tetrahydro-3-hydroxy-7-methyl-2-(prop-1-en-1-yl)-5H-furo(3,4-b)pyran-5-one [MeSH Supplementary Concept]
- 22-epicalamistrin [MeSH Supplementary Concept]
- 9-hydroxyfolianin [MeSH Supplementary Concept]
- Q-acetogenin [MeSH Supplementary Concept]
- ancepsenolide [MeSH Supplementary Concept]
- annosquatin III [MeSH Supplementary Concept]
- chamuvarinin [MeSH Supplementary Concept]
- debilisone C [MeSH Supplementary Concept]
- desepilaurallene [MeSH Supplementary Concept]
- dieporeticenin B [MeSH Supplementary Concept]
- folianin B [MeSH Supplementary Concept]
- goniodenin [MeSH Supplementary Concept]
- isodesacetyluvaricin [MeSH Supplementary Concept]
- laurendecumallene A [MeSH Supplementary Concept]
- laurendecumallene B [MeSH Supplementary Concept]
- laurendecumenyne A [MeSH Supplementary Concept]
- laurendecumenyne B [MeSH Supplementary Concept]
- laurenmariallene [MeSH Supplementary Concept]
- mitregenin [MeSH Supplementary Concept]
- muricadienin [MeSH Supplementary Concept]
- muricenin [MeSH Supplementary Concept]
- muricin J [MeSH Supplementary Concept]
- muricin K [MeSH Supplementary Concept]
- muricin L [MeSH Supplementary Concept]
- muricin M [MeSH Supplementary Concept]
- muricin N [MeSH Supplementary Concept]
- persenone C [MeSH Supplementary Concept]
- squamocin P [MeSH Supplementary Concept]
- squamostanin A [MeSH Supplementary Concept]
- squamostanin B [MeSH Supplementary Concept]
- squamostanin-C [MeSH Supplementary Concept]
- squamostanin-D [MeSH Supplementary Concept]
- tucupentol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- Annonaceous Acetogenins [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients